Unknown

Dataset Information

0

Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.


ABSTRACT:

Objective

In the general population, lipoprotein(a) [Lp(a)] has been established as an independent causal risk factor for cardiovascular disease. Lp(a) levels are to a major extent regulated by a size polymorphism in the apolipoprotein(a) [apo(a)] gene. The roles of Lp(a)/apo(a) in human immunodeficiency virus (HIV)-related elevated cardiovascular disease risk remain unclear.

Approach and results

The associations between total plasma Lp(a) level, allele-specific apo(a) level, an Lp(a) level carried by individual apo(a) alleles, and common carotid artery intima-media thickness were assessed in 150 HIV-infected and 100 HIV-uninfected women in the WIHS (Women's Interagency HIV Study). Linear regression analyses with and without adjustments were used. The cohort was young (mean age, ≈31 years), with the majority being Blacks (≈70%). The prevalence of a small size apo(a) (≤22 Kringle repeats) or a high Lp(a) level (≥30 mg/dL) was similar by HIV status. Total plasma Lp(a) level (P=0.029) and allele-specific apo(a) level carried by the smaller apo(a) sizes (P=0.022) were significantly associated with carotid artery intima-media thickness in the HIV-infected women only. After accounting for confounders (age, race, smoking, body mass index, blood pressure, hepatitis C virus coinfection, menopause, plasma lipids, treatment status, CD4+ T cell count, and HIV/RNA viral load), the association remained significant for both Lp(a) (P=0.035) and allele-specific apo(a) level carried by the smaller apo(a) sizes (P=0.010) in the HIV-infected women. Notably, none of the other lipids/lipoproteins was associated with carotid artery intima-media thickness.

Conclusions

Lp(a) and allele-specific apo(a) levels predict carotid artery intima-media thickness in HIV-infected young women. Further research is needed to identify underlying mechanisms of an increased Lp(a) atherogenicity in HIV infection.

SUBMITTER: Enkhmaa B 

PROVIDER: S-EPMC5408307 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.

Enkhmaa Byambaa B   Anuurad Erdembileg E   Zhang Wei W   Li Chin-Shang CS   Kaplan Robert R   Lazar Jason J   Merenstein Dan D   Karim Roksana R   Aouizerat Brad B   Cohen Mardge M   Butler Kenneth K   Pahwa Savita S   Ofotokun Igho I   Adimora Adaora A AA   Golub Elizabeth E   Berglund Lars L  

Arteriosclerosis, thrombosis, and vascular biology 20170323 5


<h4>Objective</h4>In the general population, lipoprotein(a) [Lp(a)] has been established as an independent causal risk factor for cardiovascular disease. Lp(a) levels are to a major extent regulated by a size polymorphism in the apolipoprotein(a) [apo(a)] gene. The roles of Lp(a)/apo(a) in human immunodeficiency virus (HIV)-related elevated cardiovascular disease risk remain unclear.<h4>Approach and results</h4>The associations between total plasma Lp(a) level, allele-specific apo(a) level, an L  ...[more]

Similar Datasets

| S-EPMC5928427 | biostudies-literature
| S-EPMC3554742 | biostudies-literature
| S-EPMC4823999 | biostudies-literature
| S-EPMC3153949 | biostudies-literature
| S-EPMC3690796 | biostudies-literature
| S-EPMC8948289 | biostudies-literature
| S-EPMC5063685 | biostudies-literature
| S-EPMC3106229 | biostudies-literature
| S-EPMC5955463 | biostudies-literature
| S-EPMC7388515 | biostudies-literature